Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2—but what is the cost? (Q84805229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739225%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739225%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2—but what is the cost? (English)

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

23 June 2024

author name string

Richard J. Mannion

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739225

23 June 2024

Adrian M. Nowitzke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739225

23 June 2024

Martin J. Wood

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20739225

23 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20739225

23 June 2024

publication date

24 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739225%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

11 February 2020

https://api.elsevier.com/content/article/PII:S152994301000519X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

https://api.elsevier.com/content/article/PII:S152994301000519X?httpAccept=text/plain

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

23 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739225%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739225%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739225%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

527-533

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739225%20AND%20SRC:MED&resulttype=core&format=json

Minimally invasive transforaminal lumbar interbody fusion (TLIF): technical feasibility and initial results.

11 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Minimally invasive transforaminal lumbar interbody fusion: indications, technique, and complications

23 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Minimally invasive transforaminal lumbar interbody fusion with reduction of spondylolisthesis: technique and outcomes after a minimum of 2 years' follow-up.

23 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Minimally invasive versus open transforaminal lumbar interbody fusion: evaluating initial experience

23 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate

23 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Clinical and radiological outcome of anterior-posterior fusion versus transforaminal lumbar interbody fusion for symptomatic disc degeneration: a retrospective comparative study of 133 patients

23 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Impact of iliac crest bone graft harvesting on fusion rates and postoperative pain during instrumented posterolateral lumbar fusion.

23 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the

23 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.

23 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis

23 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Posterior lumbar interbody fusion using rhBMP-2.

23 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results

23 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study

23 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery

23 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review

23 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Minimum 5-year follow-up of anterior column structural allografts in the thoracic and lumbar spine

23 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Surgical compared with nonoperative treatment for lumbar degenerative spondylolisthesis. four-year results in the Spine Patient Outcomes Research Trial (SPORT) randomized and observational cohorts

23 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Chronic low back pain and fusion: a comparison of three surgical techniques: a prospective multicenter randomized study from the Swedish lumbar spine study group

23 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review

23 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2.

23 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Economic evaluation of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion: an evidence-based modeling approach

23 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.

23 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications

23 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).

23 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion

23 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases

23 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions

23 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion

23 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SPINEE.2010.07.005

23 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20739225%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference